Abiopharma

New Form EFFECT - INTELLIGENT BIO SOLUTIONS INC. Filed: 2025-09-09 AccNo: 9999999995-25-002895 Size: 2 KB

New Form EFFECT - Edesa Biotech, Inc. Filed: 2025-09-09 AccNo: 9999999995-25-002894 Size: 1 KB

New Form EFFECT - Monopar Therapeutics Filed: 2025-09-09 AccNo: 9999999995-25-002897 Size: 1 KB

New Form EFFECT - Cardio Diagnostics Holdings, Inc. Filed: 2025-09-09 AccNo: 9999999995-25-002883 Size: 1 KB

New Form EFFECT - RedHill Biopharma Ltd. Filed: 2025-09-09 AccNo: 9999999995-25-002890 Size: 1 KB

New Form EFFECT - RedHill Biopharma Ltd. Filed: 2025-09-09 AccNo: 9999999995-25-002885 Size: 1 KB

New Form EFFECT - NLS Pharmaceutics Ltd. Filed: 2025-09-09 AccNo: 9999999995-25-002886 Size: 1 KB

New Form EFFECT - Jin Medical International Ltd. Filed: 2025-09-09 AccNo: 9999999995-25-002889 Size: 1 KB

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Change - Change in Issuer Name :

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

FDA approve DEFERASIROX

FDA approve OXCARBAZEPINE

FDA approve PROCHLORPERAZINE MALEATE